Covid-19 roundup: Pfizer/BioNTech release real-world evidence of vaccine efficacy; EMA gives J&J shot thumbs up
With their Covid-19 vaccine having been authorized for roughly three months, Pfizer and BioNTech have released a look into some real-world evidence regarding the shot’s effectiveness in Israel.
According to their analysis, the vaccine was at least 97% in preventing symptomatic disease, hospitalizations and death, as well as 94% against asymptomatic infections, Pfizer said in a release Thursday morning. The pair looked at data collected between Jan. 17 and March 6, when their shot was the only vaccine authorized in the country and the coronavirus variant that first emerged in the UK was the dominant strain.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
